Opioid Use

Psychiatry·MeSH: Opioid-Related Disorders

Prevalence

220.6 / 100K

Incidence

26.2 / 100K/yr

31 drugs in development·15 companies·11 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
buprenorphine	GH Research PLC (GHRS)

Phase 3(2)

Drug	Company
Dronabinol Capsules	COLLEGIUM PHARMACEUTICAL, INC (COLL)
extended-release buprenorphine	GH Research PLC (GHRS)

Phase 2(8)

Drug	Company
Brenipatide	ELI LILLY & Co (LLY)
Buprenorphine	ELI LILLY & Co (LLY)
indv-2000	Indivior Pharmaceuticals, Inc. (INDV)
indv-6001	Indivior Pharmaceuticals, Inc. (INDV)
Psilocybin	COLLEGIUM PHARMACEUTICAL, INC (COLL)
sustained-release dexamphetamine	GH Research PLC (GHRS)
Tirzepatide	Crinetics Pharmaceuticals, Inc. (CRNX)
Tirzepatide	COLLEGIUM PHARMACEUTICAL, INC (COLL)

Phase 1(4)

Drug	Company
carfentanil	Cerevel Therapeutics Holdings, Inc. (CERE)
cvl-354	Cerevel Therapeutics Holdings, Inc. (CERE)
ly2795050	Cerevel Therapeutics Holdings, Inc. (CERE)
trv734	TREVENA INC (TRVN)

Preclinical(1)

Drug	Company
opnt005	OPIANT PHARMACEUTICALS, INC. (OPNT)

Early Phase 1(11)

Drug	Company
Opioid-based anesthesia	Structure Therapeutics Inc. (GPCR)
Opioid-based anesthesia	Filana Therapeutics Inc. (FLNA)
Opioid-based anesthesia	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Opioid-based anesthesia	PROTHENA CORP PUBLIC LTD CO (PRTA)
Opioid-based anesthesia	COGNITION THERAPEUTICS INC (CGTX)
Opioid-free anesthesia	Cidara Therapeutics, Inc. (CDTX)
Opioid-free anesthesia	Structure Therapeutics Inc. (GPCR)
Opioid-free anesthesia	COGNITION THERAPEUTICS INC (CGTX)
Opioid-free anesthesia	PROTHENA CORP PUBLIC LTD CO (PRTA)
Opioid-free anesthesia	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Opioid-free anesthesia	Filana Therapeutics Inc. (FLNA)

Phase 4(4)

Drug	Company
Buprenorphine	AIM ImmunoTech Inc. (AIM)
Oxycodone	AIM ImmunoTech Inc. (AIM)
sublocade	Indivior Pharmaceuticals, Inc. (INDV)
suboxone	Indivior Pharmaceuticals, Inc. (INDV)

BioSniper tracks 31 drugs in development for Opioid Use across 15 companies.

There are 11 clinical trials targeting Opioid Use tracked by BioSniper.

The estimated prevalence of Opioid Use is approximately 220.6 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.